Avalo Therapeutics Inc

AVTXRank #97

$7.45−17.13% 1D

$11.2152-week range$24.27

Updated Oct 23, 2026, 05:44 AM UTC. Prices are snapshots and may be delayed.

Open full workspace

Avalo Therapeutics Inc price chart

−36.13% over 7D

$12.94

$7.45

Oct 21

Oct 23

AI Outlook for Avalo Therapeutics Inc

Bearish posture

Long-term trend
-54.4% vs 200-day average
Medium-term trend
-54.7% vs 50-day average
Averages
50-day above 200-day

3 more trend and momentum checks
Nearby support and resistance levels
What would strengthen or weaken the picture

See plans to unlock Open AVTX in the workspace

Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out

Avalo Therapeutics Inc performance

−17.1%

−38.0%

30D

−54.9%

90D

−59.6%

−57.6%

About Avalo Therapeutics Inc

Avalo Therapeutics Inc is a biotechnology company based in the United States, listed on NASDAQ since 2015 (ticker AVTX).

Its market capitalisation is $400 million, the #97 largest of the 117 stocks Air Radar has market-cap data for.

Avalo Therapeutics Inc market data

What is the price of Avalo Therapeutics Inc today?

Avalo Therapeutics Inc (AVTX) is at $7.45, −17.13% on the day.

What is the 52-week range of Avalo Therapeutics Inc?

Over the past year Avalo Therapeutics Inc has traded between $11.21 and $24.27. It is currently -29% of the way up that range.

What is the market cap of Avalo Therapeutics Inc?

Avalo Therapeutics Inc has a market capitalisation of $399,543,430, the #97 largest of the stocks Air Radar has market-cap data for.

Similar stocks

Recursion Pharmaceuticals, Inc.

$3.58+1.1%

PURR

Hyperliquid Strategies Inc.

$8.68−3.1%

CYPH

Cypherpunk Technologies Inc.

$2.98+1.4%

ROIV

Roivant Sciences Ltd.

$37.45+2.1%

AKBA

Akebia Therapeutics, Inc.

Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.